+499.5%
MRNA vs ONTO
+162.8%
+336.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ONTO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +6.2% | -8.4% | -2.5% |
| 7D | +5.5% | -1.0% | +6.5% | +5.5% |
| 30D | +158.7% | -2.9% | +161.6% | +151.4% |
| 3M | +182.1% | -2.5% | +184.6% | +159.1% |
| 6M | +151.8% | +28.2% | +123.6% | +108.0% |
| YTD | +393.6% | +69.8% | +323.8% | +272.6% |
| 1Y | +499.5% | +162.9% | +336.6% | +278.7% |
| All | +499.5% | +162.8% | +336.7% | +278.7% |
Cumulative growth
Daily Returns
Daily percentage return beside ONTO.
Daily Out/Under-Performance
Portfolio return minus ONTO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ONTO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ONTO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling